title: [Management of sarcoidosis-associated chronic hepatitis C virus infection: course and treatment].
authors.forename: R
authors.initials: R
authors.lastname: Longueira Suárez
authors.forename: I
authors.initials: I
authors.lastname: Ammari
authors.forename: J L
authors.initials: JL
authors.lastname: Lamas Ferreiro
authors.forename: B
authors.initials: B
authors.lastname: Sopeña Pérez-Argüelles
authors.forename: César
authors.initials: C
authors.lastname: Martínez-Vázquez
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005500:Follow-Up Studies; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D007372:Interferons / Q000627:therapeutic use*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use*; D017565:Sarcoidosis, Pulmonary / Q000150:complications* / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; D007372:Interferons; C100416:peginterferon alfa-2a; D008775:Methylprednisolone